Researchers eye SYK inhibitors for retinoblastoma
This article was originally published in Scrip
Executive Summary
Experimental drugs that block the SYK could prove effective treatments for the aggressive childhood cancer retinoblastoma if it proves possible to reformulate them for ocular use, researchers from St Jude's Children's Research Hospital have found.